- Human Biospecimens
- For Researchers
- For Biospecimen Contributors
- For Patients
August 27, 2020
A University of Central Florida research lab has developed “human-on-a-chip” technology that can be used to help assess the potential of new personalized therapy candidates for ALS.
August 18, 2020
There’s a lot of news on COVID-19 (as always). First, some very good news: Vaccine development is progressing at a surprisingly brisk pace, with researchers arriving at phase 3 trials in six months, instead of years, raising the possibility of an approved vaccine faster than ever.
August 6, 2020
Researchers at Lund University in Sweden have developed a potentially breakthrough blood test for Alzheimer’s disease, a debilitating and hard-to-diagnose condition that robs patients of their memory and independent function. If and when it’s approved for general use, the new experimental test could provide a quicker, cheaper, more widely available and more definitive way to diagnose the agonizing condition.
July 23, 2020
The largest study of its kind has demonstrated the power of biobanking, genetics and data analytics to produce new medical insights from enormous pools of patients.
July 16, 2020
Cancer often progresses under the radar, especially in its early and more treatable stages. When symptoms do arise, definitive diagnosis often requires an invasive surgical procedure. So how can we diagnose cancer earlier for more people with less effort and less discomfort? Liquid biopsy is an emerging technology aimed at addressing all of these concerns, […]
July 9, 2020
In a time when good news is desperately needed, researchers are reporting very promising trial results that could yield a robust treatment for inherited blood disorders like sickle cell anemia. The news involves an experimental therapy based on CRISPR, the revolutionary gene-editing technique, and builds on successes we blogged about in December.
June 25, 2020
COVID-19 appears to be hitting men harder than women, and four months into the pandemic, the reason is still a mystery. Scientists are looking at a range of potential factors, including immune response, a protein called ACE 2, hormones, smoking and the well-documented male reticence of going to the doctor.
June 18, 2020
Scientists in Russia may have found a new, more effective and less invasive way to detect prostate cancer, the second-most common cancer in men with nearly 1.3 million new cases and more than 350,000 deaths in 2018.
May 29, 2020
The concept is “convalescent plasma,” a time-honored healing art that has saved patients with diphtheria, measles and the Spanish flu going back to the late 19th century. Plasma is the colorless, liquid portion of the blood. In recovered COVID-19 patients, these plasma-based antibodies presumably provide a period of immunity and may also help recovery of actively infected patients.